| 1. Kym PR, Kort ME, Coghlan MJ, Moore JL, Tang R, Ratajczyk JD, Larson DP, Elmore SW, Pratt JK, Stashko MA, Falls HD, Lin CW, Nakane M, Miller L, Tyree CM, Miner JN, Jacobson PB, Wilcox DM, Nguyen P, Lane BC.. (2003) Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines., 46 (6): [PMID:12620078] [10.1021/jm020335m] |
| 2. Kwon T, Heiman AS, Oriaku ET, Yoon K, Lee HJ.. (1995) New steroidal antiinflammatory antedrugs: steroidal [16 alpha,17 alpha-d]-3'-carbethoxyisoxazolines., 38 (6): [PMID:7699698] [10.1021/jm00006a026] |
| 3. Reich MF, Johnson BD, Lenhard RH, Hanifin J. (1994) Derivatives of D-penicillamine as potential antiarthritic agents, 4 (9): [10.1016/S0960-894X(01)80249-3] |
| 4. Kundu B, Puri A, Singh G, Sahai R, Tripathi LM, Srivastava VM.. (2000) Immunomodulatory activity of hexapeptides related to proline rich peptide from colostrum., 10 (11): [PMID:10866376] [10.1016/s0960-894x(00)00220-1] |
| 5. Lombardo F, Obach RS, Shalaeva MY, Gao F.. (2004) Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics., 47 (5): [PMID:14971904] [10.1021/jm030408h] |
| 6. Stiefl N, Baumann K.. (2003) Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique., 46 (8): [PMID:12672239] [10.1021/jm021077w] |
| 7. Elmore SW, Pratt JK, Coghlan MJ, Mao Y, Green BE, Anderson DD, Stashko MA, Lin CW, Falls D, Nakane M, Miller L, Tyree CM, Miner JN, Lane B.. (2004) Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators., 14 (7): [PMID:15026058] [10.1016/j.bmcl.2004.01.044] |
| 8. Stouch TR, Jurs PC.. (1986) Computer-aided studies of the structure-activity relationships between the structure of some steroids and their antiinflammatory activity., 29 (11): [PMID:3783574] [10.1021/jm00161a001] |
| 9. Silverman BD, Platt DE.. (1996) Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition., 39 (11): [PMID:8667357] [10.1021/jm950589q] |
| 10. Kim HP, Bird J, Heiman AS, Hudson GF, Taraporewala IB, Lee HJ.. (1987) Synthesis of new antiinflammatory steroidal 20-carboxamides: (20R)- and (20S)-21-(N-substituted amino)-11 beta,17,20-trihydroxy-3,21-dioxo-1,4- pregnadiene., 30 (12): [PMID:3681894] [10.1021/jm00395a011] |
| 11. Jain AN, Koile K, Chapman D.. (1994) Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark., 37 (15): [PMID:8057280] [10.1021/jm00041a010] |
| 12. Matsuda T, Aoki T, Ohgiya T, Koshi T, Ohkuchi M, Shigyo H.. (2001) Synthesis and bioactivities of novel pyridazine derivatives: inhibitors of interleukin-1 beta (IL-1beta) production., 11 (17): [PMID:11527733] [10.1016/s0960-894x(01)00432-2] |
| 13. Matsuda T, Aoki T, Koshi T, Ohkuchi M, Shigyo H.. (2001) Synthesis and bioactivities of novel 5,6-bis(4-methoxyphenyl)-2H-pyridazin-3-one derivatives: inhibitors of interleukin-1 beta (IL-1beta) production., 11 (17): [PMID:11527734] [10.1016/s0960-894x(01)00433-4] |
| 14. Ali A, Thompson CF, Balkovec JM, Graham DW, Hammond ML, Quraishi N, Tata JR, Einstein M, Ge L, Harris G, Kelly TM, Mazur P, Pandit S, Santoro J, Sitlani A, Wang C, Williamson J, Miller DK, Thompson CM, Zaller DM, Forrest MJ, Carballo-Jane E, Luell S.. (2004) Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity., 47 (10): [PMID:15115388] [10.1021/jm030585i] |
| 15. Lombardo F, Shalaeva MY, Tupper KA, Gao F.. (2001) ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds., 44 (15): [PMID:11448232] [10.1021/jm0100990] |
| 16. Kubinyi H, Hamprecht FA, Mietzner T.. (1998) Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices., 41 (14): [PMID:9651159] [10.1021/jm970732a] |
| 17. Yoshida F, Topliss JG.. (2000) QSAR model for drug human oral bioavailability., 43 (13): [PMID:10891117] [10.1021/jm0000564] |
| 18. Friend DR, Chang GW.. (1984) A colon-specific drug-delivery system based on drug glycosides and the glycosidases of colonic bacteria., 27 (3): [PMID:6699871] [10.1021/jm00369a005] |
| 19. Kotani T, Higashiura K.. (2004) Comparative molecular active site analysis (CoMASA). 1. An approach to rapid evaluation of 3D QSAR., 47 (11): [PMID:15139751] [10.1021/jm030364c] |
| 20. Bruno-Blanch L, Gálvez J, García-Domenech R.. (2003) Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity., 13 (16): [PMID:12873507] [10.1016/s0960-894x(03)00535-3] |
| 21. Suzuki F, Kuroda T, Tamura T, Sato S, Ohmori K, Ichikawa S.. (1992) New antiinflammatory agents. 2. 5-Phenyl-3H-imidazo[4,5-c][1,8]naphthyridin-4(5H)-ones: a new class of nonsteroidal antiinflammatory agents with potent activity like glucocorticoids., 35 (15): [PMID:1495017] [10.1021/jm00093a020] |
| 22. Lombardo F, Obach RS, Shalaeva MY, Gao F.. (2002) Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data., 45 (13): [PMID:12061889] [10.1021/jm0200409] |
| 23. Coghlan MJ, Kym PR, Elmore SW, Wang AX, Luly JR, Wilcox D, Stashko M, Lin CW, Miner J, Tyree C, Nakane M, Jacobson P, Lane BC.. (2001) Synthesis and characterization of non-steroidal ligands for the glucocorticoid receptor: selective quinoline derivatives with prednisolone-equivalent functional activity., 44 (18): [PMID:11520196] [10.1021/jm010228c] |
| 24. Lombardo F, Shalaeva MY, Tupper KA, Gao F, Abraham MH.. (2000) ElogPoct: a tool for lipophilicity determination in drug discovery., 43 (15): [PMID:10956200] [10.1021/jm0000822] |
| 25. Djuric SW, BaMaung NY, Basha A, Liu H, Luly JR, Madar DJ, Sciotti RJ, Tu NP, Wagenaar FL, Wiedeman PE, Zhou X, Ballaron S, Bauch J, Chen YW, Chiou XG, Fey T, Gauvin D, Gubbins E, Hsieh GC, Marsh KC, Mollison KW, Pong M, Shaughnessy TK, Sheets MP, Smith M, Trevillyan JM, Warrior U, Wegner CD, Carter GW.. (2000) 3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulator., 43 (16): [PMID:10956206] [10.1021/jm990615a] |
| 26. Crippen GM.. (1997) Validation of EGSITE2, a mixed integer program for deducing objective site models for experimental binding data., 40 (20): [PMID:9379435] [10.1021/jm970211n] |
| 27. Pastor M, Cruciani G, McLay I, Pickett S, Clementi S.. (2000) GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors., 43 (17): [PMID:10966742] [10.1021/jm000941m] |
| 28. Bodor N, Harget AJ, Phillips EW.. (1983) Structure-activity relationships in the antiinflammatory steroids: a pattern-recognition approach., 26 (3): [PMID:6827553] [10.1021/jm00357a003] |
| 29. Bhattacharya M, Puri A, Sahai R, Haq W, Tripathi LM, Srivastava VM.. (1998) Immunosuppressant activity in human beta-casein fragment analogs., 8 (4): [PMID:9871679] [10.1016/s0960-894x(98)00022-5] |
| 30. So SS, Karplus M.. (1997) Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 1. Method and validations., 40 (26): [PMID:9435904] [10.1021/jm970487v] |
| 31. Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL.. (2001) Cheminformatic models to predict binding affinities to human serum albumin., 44 (25): [PMID:11728183] [10.1021/jm010960b] |
| 32. Good AC, So SS, Richards WG.. (1993) Structure-activity relationships from molecular similarity matrices., 36 (4): [PMID:8474098] [10.1021/jm00056a002] |
| 33. Elmore SW, Coghlan MJ, Anderson DD, Pratt JK, Green BE, Wang AX, Stashko MA, Lin CW, Tyree CM, Miner JN, Jacobson PB, Wilcox DM, Lane BC.. (2001) Nonsteroidal selective glucocorticoid modulators: the effect of C-5 alkyl substitution on the transcriptional activation/repression profile of 2,5-dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines., 44 (25): [PMID:11728194] [10.1021/jm010367u] |
| 34. Tanaka M, Chiba K, Okita M, Kaneko T, Tagami K, Hibi S, Okamoto Y, Shirota H, Goto M, Obaishi H.. (1992) A novel orally active inhibitor of IL-1 generation: synthesis and structure-activity relationships of 3-(4-hydroxy-1-naphthalenyl)-2-propenoic acid derivatives., 35 (25): [PMID:1469696] [10.1021/jm00103a003] |
| 35. Friend DR, Chang GW.. (1985) Drug glycosides: potential prodrugs for colon-specific drug delivery., 28 (1): [PMID:3965714] [10.1021/jm00379a012] |
| 36. Robinson DD, Winn PJ, Lyne PD, Richards WG.. (1999) Self-organizing molecular field analysis: a tool for structure-activity studies., 42 (4): [PMID:10052964] [10.1021/jm9810607] |
| 37. Baraldi PG, Romagnoli R, Del Carmen Nuñez M, Perretti M, Paul-Clark MJ, Ferrario M, Govoni M, Benedini F, Ongini E.. (2004) Synthesis of nitro esters of prednisolone, new compounds combining pharmacological properties of both glucocorticoids and nitric oxide., 47 (3): [PMID:14736251] [10.1021/jm030964b] |
| 38. Lantos I, Bender PE, Razgaitis KA, Sutton BM, DiMartino MJ, Griswold DE, Walz DT.. (1984) Antiinflammatory activity of 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles. Isomeric 4-pyridyl and 4-substituted phenyl derivatives., 27 (1): [PMID:6690686] [10.1021/jm00367a014] |
| 39. Tsuji K, Spears GW, Nakamura K, Tojo T, Seki N, Sugiyama A, Matsuo M.. (2002) Synthesis and antinephritic activities of quinoline-3-carboxamides and related compounds., 12 (1): [PMID:11738579] [10.1016/s0960-894x(01)00671-0] |
| 40. Thompson CF, Quraishi N, Ali A, Tata JR, Hammond ML, Balkovec JM, Einstein M, Ge L, Harris G, Kelly TM, Mazur P, Pandit S, Santoro J, Sitlani A, Wang C, Williamson J, Miller DK, Yamin TT, Thompson CM, O'Neill EA, Zaller D, Forrest MJ, Carballo-Jane E, Luell S.. (2005) Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacy., 15 (8): [PMID:15808489] [10.1016/j.bmcl.2005.02.009] |
| 41. Lill MA, Winiger F, Vedani A, Ernst B.. (2005) Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals., 48 (18): [PMID:16134935] [10.1021/jm050403f] |
| 42. Barker M, Clackers M, Copley R, Demaine DA, Humphreys D, Inglis GG, Johnston MJ, Jones HT, Haase MV, House D, Loiseau R, Nisbet L, Pacquet F, Skone PA, Shanahan SE, Tape D, Vinader VM, Washington M, Uings I, Upton R, McLay IM, Macdonald SJ.. (2006) Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series., 49 (14): [PMID:16821781] [10.1021/jm060302x] |
| 43. Regan J, Lee TW, Zindell RM, Bekkali Y, Bentzien J, Gilmore T, Hammach A, Kirrane TM, Kukulka AJ, Kuzmich D, Nelson RM, Proudfoot JR, Ralph M, Pelletier J, Souza D, Zuvela-Jelaska L, Nabozny G, Thomson DS.. (2006) Quinol-4-ones as steroid A-ring mimetics in nonsteroidal dissociated glucocorticoid agonists., 49 (26): [PMID:17181172] [10.1021/jm061273t] |
| 44. Rajakumar P, Mohammed Abdul Rasheed A, Iman Rabia A, Chamundeeswari D.. (2006) Synthesis and study of anti-inflammatory activity of some novel cyclophane amides., 16 (23): [PMID:16996736] [10.1016/j.bmcl.2006.08.124] |
| 45. Fujikawa M, Nakao K, Shimizu R, Akamatsu M.. (2007) QSAR study on permeability of hydrophobic compounds with artificial membranes., 15 (11): [PMID:17418579] [10.1016/j.bmc.2007.03.040] |
| 46. Thompson CF, Quraishi N, Ali A, Mosley RT, Tata JR, Hammond ML, Balkovec JM, Einstein M, Ge L, Harris G, Kelly TM, Mazur P, Pandit S, Santoro J, Sitlani A, Wang C, Williamson J, Miller DK, Yamin TT, Thompson CM, O'Neill EA, Zaller D, Forrest MJ, Carballo-Jane E, Luell S.. (2007) Novel glucocorticoids containing a 6,5-bicyclic core fused to a pyrazole ring: synthesis, in vitro profile, molecular modeling studies, and in vivo experiments., 17 (12): [PMID:17467988] [10.1016/j.bmcl.2007.03.103] |
| 47. Ardecky RJ, Hudson AR, Phillips DP, Tyhonas JS, Deckhut C, Lau TL, Li Y, Martinborough EA, Roach SL, Higuchi RI, Lopez FJ, Marschke KB, Miner JN, Karanewsky DS, Negro-Vilar A, Zhi L.. (2007) 5(Z)-benzylidene-1,2-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5H-1-aza-6-oxa-chrysenes as non-steroidal glucocorticoid receptor modulators., 17 (15): [PMID:17553679] [10.1016/j.bmcl.2007.05.062] |
| 48. Biggadike K, Boudjelal M, Clackers M, Coe DM, Demaine DA, Hardy GW, Humphreys D, Inglis GG, Johnston MJ, Jones HT, House D, Loiseau R, Needham D, Skone PA, Uings I, Veitch G, Weingarten GG, McLay IM, Macdonald SJ.. (2007) Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity., 50 (26): [PMID:18038970] [10.1021/jm070778w] |
| 49. Maruoka H, Muto T, Tanaka T, Imajo S, Tomimori Y, Fukuda Y, Nakatsuka T.. (2007) Development of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as orally active human chymase inhibitors., 17 (12): [PMID:17434735] [10.1016/j.bmcl.2007.03.085] |
| 50. Baert B, Deconinck E, Van Gele M, Slodicka M, Stoppie P, Bodé S, Slegers G, Vander Heyden Y, Lambert J, Beetens J, De Spiegeleer B.. (2007) Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds., 15 (22): [PMID:17827020] [10.1016/j.bmc.2007.07.050] |
| 51. Saku O, Ohta K, Arai E, Nomoto Y, Miura H, Nakamura H, Fuse E, Nakasato Y.. (2008) Synthetic study of VLA-4/VCAM-1 inhibitors: synthesis and structure-activity relationship of piperazinylphenylalanine derivatives., 18 (3): [PMID:18160288] [10.1016/j.bmcl.2007.12.014] |
| 52. Miner JN, Ardecky B, Benbatoul K, Griffiths K, Larson CJ, Mais DE, Marschke K, Rosen J, Vajda E, Zhi L, Negro-Vilar A.. (2007) Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile., 104 (49): [PMID:18032610] [10.1073/pnas.0705517104] |
| 53. Roach SL, Higuchi RI, Adams ME, Liu Y, Karanewsky DS, Marschke KB, Mais DE, Miner JN, Zhi L.. (2008) Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines., 18 (12): [PMID:18513967] [10.1016/j.bmcl.2008.05.029] |
| 54. Cho JY, Baik KU, Yoo ES, Yoshikawa K, Park MH.. (2000) In vitro antiinflammatory effects of neolignan woorenosides from the rhizomes of Coptis japonica., 63 (9): [PMID:11000020] [10.1021/np9902791] |
| 55. Koul S, Razdan TK, Andotra CS.. (2003) Acinospesigenin-A, -B, and -C: three new triterpenoids from Phytolacca acinosa., 66 (8): [PMID:12932140] [10.1021/np030070u] |
| 56. Chuang S, Velkov T, Horne J, Porter CJ, Scanlon MJ.. (2008) Characterization of the drug binding specificity of rat liver fatty acid binding protein., 51 (13): [PMID:18533710] [10.1021/jm701192w] |
| 57. Ishikawa M, Ninomiya T, Akabane H, Kushida N, Tsujiuchi G, Ohyama M, Gomi S, Shito K, Murata T.. (2009) Pseurotin A and its analogues as inhibitors of immunoglobulin E [correction of immunoglobuline E] production., 19 (5): [PMID:19179074] [10.1016/j.bmcl.2009.01.029] |
| 58. Yang BV, Vaccaro W, Doweyko AM, Doweyko LM, Huynh T, Tortolani D, Nadler SG, McKay L, Somerville J, Holloway DA, Habte S, Weinstein DS, Barrish JC.. (2009) Discovery of novel dihydro-9,10-ethano-anthracene carboxamides as glucocorticoid receptor modulators., 19 (8): [PMID:19321341] [10.1016/j.bmcl.2009.03.006] |
| 59. Ruiz JF, Radics G, Windle H, Serra HO, Simplício AL, Kedziora K, Fallon PG, Kelleher DP, Gilmer JF.. (2009) Design, synthesis, and pharmacological effects of a cyclization-activated steroid prodrug for colon targeting in inflammatory bowel disease., 52 (10): [PMID:19397323] [10.1021/jm8016317] |
| 60. Shikishima Y, Takaishi Y, Honda G, Ito M, Takeda Y, Tori M, Takaoka S, Kodzhimatov OK, Ashurmetov O.. (2002) Sesquiterpenes from Ferula penninervis., 65 (12): [PMID:12502335] [10.1021/np020014d] |
| 61. Barnett HA, Coe DM, Cooper TW, Jack TI, Jones HT, Macdonald SJ, McLay IM, Rayner N, Sasse RZ, Shipley TJ, Skone PA, Somers GI, Taylor S, Uings IJ, Woolven JM, Weingarten GG.. (2009) Aryl aminopyrazole benzamides as oral non-steroidal selective glucocorticoid receptor agonists., 19 (1): [PMID:19019676] [10.1016/j.bmcl.2008.10.128] |
| 62. Duan H, Takaishi Y, Momota H, Ohmoto Y, Taki T, Jia Y, Li D.. (1999) Immunosuppressive diterpenoids from Tripterygium wilfordii., 62 (11): [PMID:10579865] [10.1021/np9902183] |
| 63. Sagawa T, Takaishi Y, Fujimoto Y, Duque C, Osorio C, Ramos F, Garzon C, Sato M, Okamoto M, Oshikawa T, Ahmed SU.. (2005) Cyclobutane dimers from the Colombian medicinal plant Achyrocline bogotensis., 68 (4): [PMID:15844937] [10.1021/np040187y] |
| 64. Pedersen JM, Matsson P, Bergström CA, Norinder U, Hoogstraate J, Artursson P.. (2008) Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)., 51 (11): [PMID:18457386] [10.1021/jm7015683] |
| 65. Angell R, Aston NM, Bamborough P, Buckton JB, Cockerill S, deBoeck SJ, Edwards CD, Holmes DS, Jones KL, Laine DI, Patel S, Smee PA, Smith KJ, Somers DO, Walker AL.. (2008) Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity., 18 (15): [PMID:18614366] [10.1016/j.bmcl.2008.06.048] |
| 66. Li H, Sun J, Sui X, Liu J, Yan Z, Liu X, Sun Y, He Z.. (2009) First-principle, structure-based prediction of hepatic metabolic clearance values in human., 44 (4): [PMID:18768239] [10.1016/j.ejmech.2008.07.027] |
| 67. Chen B, Kawazoe K, Takaishi Y, Honda G, Itoh M, Takeda Y, Kodzhimatov OK, Ashurmetov O.. (2000) Prenylated benzoic acid derivatives from Ferula kuhistanica., 63 (3): [PMID:10757719] [10.1021/np990338a] |
| 68. Duan H, Takaishi Y, Momota H, Ohmoto Y, Taki T, Jia Y, Li D.. (2001) Immunosuppressive sesquiterpene alkaloids from Tripterygium wilfordii., 64 (5): [PMID:11374948] [10.1021/np000504a] |
| 69. Ali A, Balkovec JM, Greenlee M, Hammond ML, Rouen G, Taylor G, Einstein M, Ge L, Harris G, Kelly TM, Mazur P, Pandit S, Santoro J, Sitlani A, Wang C, Williamson J, Forrest MJ, Carballo-Jane E, Luell S, Lowitz K, Visco D.. (2008) Discovery of betamethasone 17alpha-carbamates as dissociated glucocorticoid receptor modulators in the rat., 16 (16): [PMID:18691892] [10.1016/j.bmc.2008.07.037] |
| 70. Pérez-Garrido A, Morales Helguera A, Abellán Guillén A, Cordeiro MN, Garrido Escudero A.. (2009) Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins., 17 (2): [PMID:19056282] [10.1016/j.bmc.2008.11.040] |
| 71. Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, Miller HR, El-Kattan A.. (2009) Physicochemical determinants of human renal clearance., 52 (15): [PMID:19445515] [10.1021/jm900403j] |
| 72. Kubota K, Kurebayashi H, Miyachi H, Tobe M, Onishi M, Isobe Y.. (2009) Synthesis and structure-activity relationships of phenothiazine carboxylic acids having pyrimidine-dione as novel histamine H(1) antagonists., 19 (10): [PMID:19362477] [10.1016/j.bmcl.2009.03.124] |
| 73. Said SA, Amr Ael-G, Sabry NM, Abdalla MM.. (2009) Analgesic, anticonvulsant and anti-inflammatory activities of some synthesized benzodiazipine, triazolopyrimidine and bis-imide derivatives., 44 (12): [PMID:19682771] [10.1016/j.ejmech.2009.07.013] |
| 74. Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, Troutman MD.. (2010) Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination., 53 (3): [PMID:20070106] [10.1021/jm901371v] |
| 75. Sui X, Sun J, Li H, Wang Y, Liu J, Liu X, Zhang W, Chen L, He Z.. (2009) Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data., 44 (11): [PMID:19586686] [10.1016/j.ejmech.2009.06.004] |
| 76. Onnis V, Kinsella GK, Carta G, Jagoe WN, Price T, Williams DC, Fayne D, Lloyd DG.. (2010) Virtual screening for the identification of novel nonsteroidal glucocorticoid modulators., 53 (8): [PMID:20334371] [10.1021/jm901452y] |
| 77. Guerra A, Campillo NE, Páez JA.. (2010) Neural computational prediction of oral drug absorption based on CODES 2D descriptors., 45 (3): [PMID:20022146] [10.1016/j.ejmech.2009.11.034] |
| 78. Shen Y, Boivin R, Yoneda N, Du H, Schiller S, Matsushima T, Goto M, Shirota H, Gusovsky F, Lemelin C, Jiang Y, Zhang Z, Pelletier R, Ikemori-Kawada M, Kawakami Y, Inoue A, Schnaderbeck M, Wang Y.. (2010) Discovery of anti-inflammatory clinical candidate E6201, inspired from resorcylic lactone LL-Z1640-2, III., 20 (10): [PMID:20399648] [10.1016/j.bmcl.2010.03.087] |
| 79. Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA.. (2010) 5-Functionalized indazoles as glucocorticoid receptor agonists., 20 (10): [PMID:20427184] [10.1016/j.bmcl.2010.04.012] |
| 80. Riether D, Harcken C, Razavi H, Kuzmich D, Gilmore T, Bentzien J, Pack EJ, Souza D, Nelson RM, Kukulka A, Fadra TN, Zuvela-Jelaska L, Pelletier J, Dinallo R, Panzenbeck M, Torcellini C, Nabozny GH, Thomson DS.. (2010) Nonsteroidal dissociated glucocorticoid agonists containing azaindoles as steroid A-ring mimetics., 53 (18): [PMID:20735001] [10.1021/jm100751q] |
| 81. Kularatne SA, Venkatesh C, Santhapuram HK, Wang K, Vaitilingam B, Henne WA, Low PS.. (2010) Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs., 53 (21): [PMID:20936874] [10.1021/jm100729b] |
| 82. Obach RS, Lombardo F, Waters NJ.. (2008) Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds., 36 (7): [PMID:18426954] [10.1124/dmd.108.020479] |
| 83. Roach SL, Higuchi RI, Hudson AR, Adams ME, Syka PM, Mais DE, Miner JN, Marschke KB, Zhi L.. (2011) Tetrahydroquinoline glucocorticoid receptor agonists: discovery of a 3-hydroxyl for improving receptor selectivity., 21 (1): [PMID:21115247] [10.1016/j.bmcl.2010.11.047] |
| 84. Hudson AR, Higuchi RI, Roach SL, Adams ME, Vassar A, Syka PM, Mais DE, Miner JN, Marschke KB, Zhi L.. (2011) Discovery of orally available tetrahydroquinoline-based glucocorticoid receptor agonists., 21 (6): [PMID:21316964] [10.1016/j.bmcl.2011.01.093] |
| 85. Roach SL, Higuchi RI, Hudson AR, Vassar A, Grant VH, Lamer R, Hooper C, Rungta D, Syka PM, Mais DE, Marschke KB, Zhi L.. (2011) Tetrahydroquinolin-3-yl carbamate glucocorticoid receptor agonists with reduced PEPCK activation., 21 (6): [PMID:21349714] [10.1016/j.bmcl.2011.01.106] |
| 86. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 87. Unpublished dataset, |
| 88. PubChem BioAssay data set, |
| 89. Hudson AR, Higuchi RI, Roach SL, Valdez LJ, Adams ME, Vassar A, Rungta D, Syka PM, Mais DE, Marschke KB, Zhi L.. (2011) Nonsteroidal 2,3-dihydroquinoline glucocorticoid receptor agonists with reduced PEPCK activation., 21 (6): [PMID:21324689] [10.1016/j.bmcl.2011.01.104] |
| 90. Aston NM, Bamborough P, Buckton JB, Edwards CD, Holmes DS, Jones KL, Patel VK, Smee PA, Somers DO, Vitulli G, Walker AL.. (2009) p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression., 52 (20): [PMID:19772287] [10.1021/jm9004779] |
| 91. Yang BV, Weinstein DS, Doweyko LM, Gong H, Vaccaro W, Huynh T, Xiao HY, Doweyko AM, McKay L, Holloway DA, Somerville JE, Habte S, Cunningham M, McMahon M, Townsend R, Shuster D, Dodd JH, Nadler SG, Barrish JC.. (2010) Dimethyl-diphenyl-propanamide derivatives as nonsteroidal dissociated glucocorticoid receptor agonists., 53 (23): [PMID:21073190] [10.1021/jm100957a] |
| 92. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
| 93. Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W.. (2011) FDA-approved drug labeling for the study of drug-induced liver injury., 16 (15-16): [PMID:21624500] [10.1016/j.drudis.2011.05.007] |
| 94. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 95. Weinstein DS, Gong H, Doweyko AM, Cunningham M, Habte S, Wang JH, Holloway DA, Burke C, Gao L, Guarino V, Carman J, Somerville JE, Shuster D, Salter-Cid L, Dodd JH, Nadler SG, Barrish JC.. (2011) Azaxanthene based selective glucocorticoid receptor modulators: design, synthesis, and pharmacological evaluation of (S)-4-(5-(1-((1,3,4-thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and its methylene homologue (BMS-791826)., 54 (20): [PMID:21899328] [10.1021/jm200879j] |
| 96. Betageri R, Gilmore T, Kuzmich D, Kirrane TM, Bentzien J, Wiedenmayer D, Bekkali Y, Regan J, Berry A, Latli B, Kukulka AJ, Fadra TN, Nelson RM, Goldrick S, Zuvela-Jelaska L, Souza D, Pelletier J, Dinallo R, Panzenbeck M, Torcellini C, Lee H, Pack E, Harcken C, Nabozny G, Thomson DS.. (2011) Non-steroidal dissociated glucocorticoid agonists: indoles as A-ring mimetics and function-regulating pharmacophores., 21 (22): [PMID:21963986] [10.1016/j.bmcl.2011.09.018] |
| 97. Biju P, McCormick K, Aslanian R, Berlin M, Solomon D, Wang H, Lee YJ, Bitar R, Prelusky D, McLeod R, Jia Y, Fernandez X, Eckel S, House A, Lieber G, Jimenez J, Kelly G, Chapman R, Phillips J, Anthes J.. (2012) Steroidal C-21 heteroaryl thioethers (Part 2): discovery of orally bioavailable selective glucocorticoid receptor modulators (dissociated steroids)., 22 (2): [PMID:22197391] [10.1016/j.bmcl.2011.11.120] |
| 98. Mirguet O, Lamotte Y, Donche F, Toum J, Gellibert F, Bouillot A, Gosmini R, Nguyen VL, Delannée D, Seal J, Blandel F, Boullay AB, Boursier E, Martin S, Brusq JM, Krysa G, Riou A, Tellier R, Costaz A, Huet P, Dudit Y, Trottet L, Kirilovsky J, Nicodeme E.. (2012) From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151., 22 (8): [PMID:22386529] [10.1016/j.bmcl.2012.01.125] |
| 99. Biju P, Wang H, Anthes J, McCormick K, Aslanian R, Berlin M, Bitar R, Lim YH, Lee YJ, Prelusky D, Mcleod R, Jia Y, Fernandez X, Lieber G, Jimenez J, Eckel S, House A, Chapman R, Phillips J.. (2012) Steroidal C-21 heteroaryl thioethers. Part 3: pregn-4-eno-[3,2-c]pyrazole fused A ring modified steroids as selective glucocorticoid receptor modulators (dissociated steroids)., 22 (9): [PMID:22465636] [10.1016/j.bmcl.2012.03.015] |
| 100. Rajakumar P, Padmanabhan R, Rajesh N.. (2012) Synthesis, study on anti-arthritic, anti-inflammatory activity and toxicity of some novel bis-oxy cyclophane diamides., 22 (11): [PMID:22542015] [10.1016/j.bmcl.2012.04.010] |
| 101. Yates CR, Chang C, Kearbey JD, Yasuda K, Schuetz EG, Miller DD, Dalton JT, Swaan PW.. (2003) Structural determinants of P-glycoprotein-mediated transport of glucocorticoids., 20 (1): [PMID:14661924] [10.1023/b:pham.0000003377.39548.f6] |
| 102. Troutman MD, Thakker DR.. (2003) Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium., 20 (1): [PMID:12948019] [10.1023/a:1025001131513] |
| 103. Bossuyt X, Müller M, Hagenbuch B, Meier PJ.. (1996) Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver., 276 (1): [PMID:8786566] |
| 104. Karssen AM, Meijer OC, van der Sandt IC, De Boer AG, De Lange EC, De Kloet ER.. (2002) The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone., 175 (1): [PMID:12379510] [10.1677/joe.0.1750251] |
| 105. Masuda S, Ibaramoto K, Takeuchi A, Saito H, Hashimoto Y, Inui KI.. (1999) Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney., 55 (1): [PMID:10101033] |
| 106. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 107. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P.. (2012) Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions., 55 (10): [PMID:22541068] [10.1021/jm300212s] |
| 108. Frankish N, Sheridan H.. (2012) 6-(methylamino)hexane-1,2,3,4,5-pentanol 4-(((1S,2S)-1-hydroxy-2,3-dihydro-1H,1'H-[2,2-biinden]-2-yl)methyl)benzoate (PH46A): a novel small molecule with efficacy in murine models of colitis., 55 (11): [PMID:22663546] [10.1021/jm300390f] |
| 109. Akamatsu M.. (2011) Importance of physicochemical properties for the design of new pesticides., 59 (7): [PMID:20879794] [10.1021/jf102525e] |
| 110. Rajadurai R, Padmanabhan R, Ananthan S. (2013) Synthesis and biological evaluation of diamide derivatives of (S)-BINOL and biphenyl as potential anti-inflammatory/anti-arthritic agents, 22 (9): [10.1007/s00044-012-0410-6] |
| 111. PubChem BioAssay data set, |
| 112. Reeves EK, Hoffman EP, Nagaraju K, Damsker JM, McCall JM.. (2013) VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid., 21 (8): [PMID:23498916] [10.1016/j.bmc.2013.02.009] |
| 113. Abdulla MM, Amr AEE, Al-Omar MA, Hussain AA, Shalaby AFA. (2013) Synthesis and pharmacological activities of some novel 5-chloro-N-(4-(1,5-(disubstituted)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-methoxybenzamide derivatives, [10.1007/s00044-013-0807-x] |
| 114. Akama T, Dong C, Virtucio C, Freund YR, Chen D, Orr MD, Jacobs RT, Zhang YK, Hernandez V, Liu Y, Wu A, Bu W, Liu L, Jarnagin K, Plattner JJ.. (2013) Discovery and structure-activity relationships of 6-(benzoylamino)benzoxaboroles as orally active anti-inflammatory agents., 23 (21): [PMID:24075731] [10.1016/j.bmcl.2013.08.096] |
| 115. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP.. (2013) Structure-based identification of OATP1B1/3 inhibitors., 83 (6): [PMID:23571415] [10.1124/mol.112.084152] |
| 116. Carson MW, Luz JG, Suen C, Montrose C, Zink R, Ruan X, Cheng C, Cole H, Adrian MD, Kohlman DT, Mabry T, Snyder N, Condon B, Maletic M, Clawson D, Pustilnik A, Coghlan MJ.. (2014) Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design., 57 (3): [PMID:24446728] [10.1021/jm401616g] |
| 117. Harcken C, Riether D, Kuzmich D, Liu P, Betageri R, Ralph M, Emmanuel M, Reeves JT, Berry A, Souza D, Nelson RM, Kukulka A, Fadra TN, Zuvela-Jelaska L, Dinallo R, Bentzien J, Nabozny GH, Thomson DS.. (2014) Identification of highly efficacious glucocorticoid receptor agonists with a potential for reduced clinical bone side effects., 57 (4): [PMID:24506830] [10.1021/jm4019178] |
| 118. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
| 119. PubChem BioAssay data set, |
| 120. PubChem BioAssay data set, |
| 121. Razavi H, Riether D, Harcken C, Bentzien J, Dinallo RM, Souza D, Nelson RM, Kukulka A, Fadra-Khan TN, Pack EJ, Zuvela-Jelaska L, Pelletier J, Panzenbeck M, Torcellini CA, Proudfoot JR, Nabozny GH, Thomson DS.. (2014) Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore., 24 (8): [PMID:24656565] [10.1016/j.bmcl.2014.03.005] |
| 122. Hong CI, Nechaev A, West CR.. (1979) Nucleoside conjugates as potential antitumor agents. 2. Synthesis and biological activity of 1-(beta-D-arabinofuranosyl)cytosine conjugates of prednisolone and prednisone., 22 (11): [PMID:118258] [10.1021/jm00197a030] |
| 123. Justice JB.. (1978) A Fujita--Ban structure--activity analysis of 44 steroids., 21 (5): [PMID:660591] [10.1021/jm00203a011] |
| 124. Gong H, Yang M, Xiao Z, Doweyko AM, Cunningham M, Wang J, Habte S, Holloway D, Burke C, Shuster D, Gao L, Carman J, Somerville JE, Nadler SG, Salter-Cid L, Barrish JC, Weinstein DS.. (2014) Discovery of acylurea isosteres of 2-acylaminothiadiazole in the azaxanthene series of glucocorticoid receptor agonists., 24 (15): [PMID:24980053] [10.1016/j.bmcl.2014.06.010] |
| 125. Zanelli U, Caradonna NP, Hallifax D, Turlizzi E, Houston JB.. (2012) Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs., 40 (1): [PMID:21998403] [10.1124/dmd.111.042309] |
| 126. Ren S, Zeng J, Mei Y, Zhang JZ, Yan SF, Fei J, Chen L.. (2013) Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors., 41 (1): [PMID:23033255] [10.1124/dmd.112.048264] |
| 127. Drug metabolism data, |
| 128. PubChem BioAssay data set, |
| 129. (2014) Tricyclic compounds, compositions, and methods, |
| 130. Khan R, Basha A, Goverdhanam R, Rao PC, Tanemura Y, Fujimoto Y, Begum AS.. (2015) Attenuation of TNF-α secretion by L-proline-based cyclic dipeptides produced by culture broth of Pseudomonas aeruginosa., 25 (24): [PMID:26546220] [10.1016/j.bmcl.2015.10.075] |
| 131. Tobe M, Tsuboi K, Hasegawa F, Fujiwara N, Inoue Y, Isobe M, Isobe Y.. (2016) Synthesis and biological evaluation of novel orally available 1-phenyl-6-aminouracils containing dimethyldihydrobenzofuranol structure for the treatment of allergic skin diseases., 26 (4): [PMID:26786694] [10.1016/j.bmcl.2016.01.019] |
| 132. Agarwal S, Patil A, Aware U, Deshmukh P, Darji B, Sasane S, Sairam KV, Priyadarsiny P, Giri P, Patel H, Giri S, Jain M, Desai RC.. (2016) Discovery of a Potent and Orally Efficacious TGR5 Receptor Agonist., 7 (1): [PMID:26819665] [10.1021/acsmedchemlett.5b00323] |
| 133. Haile PA, Votta BJ, Marquis RW, Bury MJ, Mehlmann JF, Singhaus R, Charnley AK, Lakdawala AS, Convery MA, Lipshutz DB, Desai BM, Swift B, Capriotti CA, Berger SB, Mahajan MK, Reilly MA, Rivera EJ, Sun HH, Nagilla R, Beal AM, Finger JN, Cook MN, King BW, Ouellette MT, Totoritis RD, Pierdomenico M, Negroni A, Stronati L, Cucchiara S, Ziółkowski B, Vossenkämper A, MacDonald TT, Gough PJ, Bertin J, Casillas LN.. (2016) The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase., 59 (10): [PMID:27109867] [10.1021/acs.jmedchem.6b00211] |
| 134. WHO Anatomical Therapeutic Chemical Classification, |
| 135. British National Formulary (72nd edition), |
| 136. Watterson SH, De Lucca GV, Shi Q, Langevine CM, Liu Q, Batt DG, Beaudoin Bertrand M, Gong H, Dai J, Yip S, Li P, Sun D, Wu DR, Wang C, Zhang Y, Traeger SC, Pattoli MA, Skala S, Cheng L, Obermeier MT, Vickery R, Discenza LN, D'Arienzo CJ, Zhang Y, Heimrich E, Gillooly KM, Taylor TL, Pulicicchio C, McIntyre KW, Galella MA, Tebben AJ, Muckelbauer JK, Chang C, Rampulla R, Mathur A, Salter-Cid L, Barrish JC, Carter PH, Fura A, Burke JR, Tino JA.. (2016) Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton's Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers., 59 (19): [PMID:27583770] [10.1021/acs.jmedchem.6b01088] |
| 137. Hemmerling M, Edman K, Lepistö M, Eriksson A, Ivanova S, Dahmén J, Rehwinkel H, Berger M, Hendrickx R, Dearman M, Jensen TJ, Wissler L, Hansson T.. (2016) Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators., 26 (23): [PMID:27810243] [10.1016/j.bmcl.2016.10.052] |
| 138. DrugMatrix, [10.6019/CHEMBL3885881] |
| 139. (2011) Goodman and Gilman Ed. 12 | The Pharmaceutical Basis of Therapeutics| Table AII-I: Pharmacokinetic Data, |
| 140. Hoemann M, Wilson N, Argiriadi M, Banach D, Burchat A, Calderwood D, Clapham B, Cox P, Duignan DB, Konopacki D, Somal G, Vasudevan A.. (2016) Synthesis and optimization of furano[3,2-d]pyrimidines as selective spleen tyrosine kinase (Syk) inhibitors., 26 (22): [PMID:27789138] [10.1016/j.bmcl.2016.09.077] |
| 141. Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW, Lightfoot-Dunn R, Hamadeh HK.. (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development., 118 (2): [PMID:20829430] [10.1093/toxsci/kfq269] |
| 142. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T.. (2012) Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification., 40 (12): [PMID:22961681] [10.1124/dmd.112.047068] |
| 143. Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK.. (2013) A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development., 136 (1): [PMID:23956101] [10.1093/toxsci/kft176] |
| 144. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 145. Berger M, Rehwinkel H, Schmees N, Schäcke H, Edman K, Wissler L, Reichel A, Jaroch S.. (2017) Discovery of new selective glucocorticoid receptor agonist leads., 27 (3): [PMID:28043796] [10.1016/j.bmcl.2016.12.047] |
| 146. Ripa L, Edman K, Dearman M, Edenro G, Hendrickx R, Ullah V, Chang HF, Lepistö M, Chapman D, Geschwindner S, Wissler L, Svanberg P, Lawitz K, Malmberg J, Nikitidis A, Olsson RI, Bird J, Llinas A, Hegelund-Myrbäck T, Berger M, Thorne P, Harrison R, Köhler C, Drmota T.. (2018) Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile., 61 (5): [PMID:29424542] [10.1021/acs.jmedchem.7b01690] |
| 147. Liu W, Huang S, Li Y, Li Y, Li D, Wu P, Wang Q, Zheng X, Zhang K.. (2018) Glycyrrhizic acid from licorice down-regulates inflammatory responses via blocking MAPK and PI3K/Akt-dependent NF-κB signalling pathways in TPA-induced skin inflammation., 9 (9): [PMID:30288224] [10.1039/C8MD00288F] |
| 148. Unpublished dataset, |
| 149. Franck Touret, Magali Gilles, Karine Barral, Antoine Nougairède, Etienne Decroly, Xavier de Lamballerie, Bruno Coutard. (2020) In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication, [10.1101/2020.04.03.023846] |
| 150. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
| 151. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson. (2020) Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2, [10.1101/2020.04.21.054387] |
| 152. Badarau E, Robert F, Massip S, Jakob F, Lucas S, Friebe D, Hennen S, Frormann S, Ghosez L.. (2019) Discovery of a subnanomolar and selective spirocyclic agonist of the glucocorticoid receptor., 161 [PMID:30384041] [10.1016/j.ejmech.2018.10.032] |
| 153. Haile PA, Casillas LN, Votta BJ, Wang GZ, Charnley AK, Dong X, Bury MJ, Romano JJ, Mehlmann JF, King BW, Erhard KF, Hanning CR, Lipshutz DB, Desai BM, Capriotti CA, Schaeffer MC, Berger SB, Mahajan MK, Reilly MA, Nagilla R, Rivera EJ, Sun HH, Kenna JK, Beal AM, Ouellette MT, Kelly M, Stemp G, Convery MA, Vossenkämper A, MacDonald TT, Gough PJ, Bertin J, Marquis RW.. (2019) Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases., 62 (14): [PMID:31265286] [10.1021/acs.jmedchem.9b00575] |
| 154. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 155. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 156. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 157. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 158. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of NIH (USA) - Clinical Collection, [10.6019/CHEMBL4513141] |
| 159. Unpublished dataset, |
| 160. Kurma SH, Karri S, Kuncha M, Sistla R, Bhimapaka CR.. (2020) Synthesis and anti-inflammatory activity of 2-oxo-2H-chromenyl and 2H-chromenyl-5-oxo-2,5-dihydrofuran-3-carboxylates., 30 (16): [PMID:32631542] [10.1016/j.bmcl.2020.127341] |
| 161. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 162. Vasiljevic, Bojana R., Petri, Edward T., Bekic, Sofija S., Celic, Andjelka S., Grbovic, Ljubica M., Pavlovic, Ksenija J.. (2021) Microwave-assisted green synthesis of bile acid derivatives and evaluation of glucocorticoid receptor binding, 12 (2): [PMID:34046616] [10.1039/d0md00311e] |
| 163. Madasu C,Karri S,Sangaraju R,Sistla R,Uppuluri MV. (2020) Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3)., 188 [PMID:31883489] [10.1016/j.ejmech.2019.111974] |
| 164. Gan Q,Lin C,Lu C,Chang Y,Che Q,Zhang G,Zhu T,Gu Q,Wu Z,Li M,Li D. (2020) Staprexanthones, Xanthone-Type Stimulators of Pancreatic β-Cell Proliferation from a Mangrove Endophytic Fungus., 83 (10): [PMID:32966070] [10.1021/acs.jnatprod.0c00535] |
| 165. Dąbrowska M, Starek M, Chłoń-Rzepa G, Zagórska A, Komsta Ł, Jankowska A, Ślusarczyk M, Pawłowski M.. (2021) Estimation of the lipophilicity of purine-2,6-dione-based TRPA1 antagonists and PDE4/7 inhibitors with analgesic activity., 49 [PMID:34391892] [10.1016/j.bmcl.2021.128318] |
| 166. Sreekantha RK, Mussari CP, Dodd DS, Pasunoori L, Hegde S, Posy SL, Critton D, Ruepp S, Subramanian M, Salter-Cid LM, Tagore DM, Sarodaya S, Dudhgaonkar S, Poss MA, Schieven GL, Carter PH, Macor JE, Dyckman AJ.. (2022) Identification of 2-Pyridinylindole-Based Dual Antagonists of Toll-like Receptors 7 and 8 (TLR7/8)., 13 (5.0): [PMID:35586440] [10.1021/acsmedchemlett.2c00049] |
| 167. Pillaiyar T, Meenakshisundaram S, Manickam M, Sankaranarayanan M.. (2020) A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery., 195 [PMID:32283298] [10.1016/j.ejmech.2020.112275] |
| 168. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
| 169. European Medicines Agency, |
